Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Current assets:    
Cash $ 48,440 $ 14,326
Accounts receivable (net of allowance of $0 and $0, respectively) 382
Inventories 103,209 95,865
Other current assets 3,210 3,491
Total current assets 154,859 114,064
Total assets 154,859 114,064
Current liabilities:    
Accounts payable 215,782 205,961
Accrued expense-related party 197,974 180,000
Convertible notes payable-net of debt discounts and unamortized beneficial conversion feature 633,870 151,020
Fair value of derivative liabilities 1,765,187 44,022
Short-term borrowings 1,000 3,096
Advance from Shareholders 995
Total current liabilities 2,813,813 585,094
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 42,608,329 issued and outstanding as of June 30, 2018 and 29,724,432 outstanding as of June 30, 2017, respectively) 42,608 29,724
Additional paid in capital 5,919,152 2,880,467
Accumulated deficit (8,620,714) (3,381,221)
Total stockholders' deficit (2,658,954) (471,030)
Total Liabilities and Stockholders' Deficit $ 154,859 $ 114,064